Amplia Therapeutics (ASX:ATX) plans to expand its US presence, including via a filing to uplist from the Pink Sheet to the OTCQB exchange, according to a Friday Australian bourse filing.
The firm is embarking on an expanded capital markets campaign, which includes activities with several financial institutions.
The firm's shares jumped 5% in recent trading on the Australian bourse on Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.